Quick Answer
ANI PHARMACEUTICALS INC reported Revenue From Contract With Customer Excluding Assessed Tax of $883.37 million for the year ending 2025.
- ANI PHARMACEUTICALS INC showed an increase of +43.8% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from ANI PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2018 to 2025), ANI PHARMACEUTICALS INC's Revenue From Contract With Customer Excluding Assessed Tax has grown by 338.2%.
- Historical annual values: Fiscal year 2025: $883.37 million | Fiscal year 2024: $614.38 million | Fiscal year 2023: $486.82 million | Fiscal year 2022: $316.39 million | Fiscal year 2021: $216.14 million | Fiscal year 2020: $208.48 million | Fiscal year 2019: $206.55 million | Fiscal year 2018: $201.58 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: